Insights On Enterprise Solutions

  1. TESSA® Platform Optimization For AAV Manufacture Efficiency 12/15/2025

    Optimized TESSA® platform boosts AAV yields up to 30-fold, improves capsid quality, and reduces costs by 85%, enabling scalable, contamination-free manufacturing for advanced gene therapy applications.

  2. Silencing Lentiviral Cargo For Cell Therapy 12/15/2025

    Silencing lentiviral cargo genes boosts vector yield, enhances cell viability, and reduces impurities, enabling scalable, cost-effective manufacturing for complex gene therapies.

  3. Advancing Scalable Vector Production For AAV-Based Treatments 12/15/2025

    TESSA® enables scalable, high-yield AAV manufacturing with minimal contamination, delivering >10¹⁷ genome copies per 200L run and supporting efficient, GMP-compliant production for diverse serotypes.

  4. Optimizing Lentiviral Producer Cell Line Yield 12/15/2025

    Producer cell lines boost lentiviral manufacturing efficiency via high-density culture, multiple harvests, and additive optimization for scalable production.

  5. NGS Bioinformatics Pipelines For Enhanced Viral Vector QC And Analytics 12/15/2025

    Advanced NGS bioinformatics pipelines ensure viral vector integrity, detect contaminants, and predict splicing patterns, enabling precise quality control for safer, more effective gene therapy development.

  6. Enhancing Lentiviral Vector Titre By Limiting Auto-Transduction 12/15/2025

    Limiting auto-transduction with Additive X boosts lentiviral vector titres by 4.2-fold, reduces reintegration events, and optimizes continuous production processes for advanced cell therapy applications.

  7. Doubling Up For Speed In Biomanufacturing 12/12/2025

    Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

  8. CDMO Or No CDMO... That Is The Question 12/12/2025

    Success depends on assessing internal capabilities and knowing when outsourcing can accelerate timelines. Learn how strategic decisions reduce risk, avoid costly delays, and keep your organization competitive.

  9. Choosing The Best mRNA Manufacturing Strategy 12/12/2025

    Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.

  10. CDMOs - Key Collaborators In Streamlining Drug Development 12/12/2025

    Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.